A new clinical framework redefines the diagnosis of COPD Exacerbations

2 years ago

The recommendations of an international expert panel to update the definition and severity classification of chronic obstructive pulmonary disease (COPD)…

Hirsh Kumar Mohindra Rapidly Expanding Northshore Clinical Labs’ Partnerships

2 years ago

CHICAGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Chicago-based Northshore Clinical Labs is a high-capacity laboratory that can test many thousands…

LIDDS Announces Appointment of Matthew Lindon as Chief Scientific Officer

2 years ago

UPPSALA, SWEDEN – LIDDS AB (publ) announced today that Matthew Lindon has been appointed Chief Scientific Officer (CSO) of LIDDS…

Sorrento Therapeutics Announces FDA Clearance of Its IND Application of Next Generation oHSV Oncolytic Virus STI-1386 for Patients With Relapsed and Refractory Solid Tumors

2 years ago

SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that the U.S. Food…

Meru Health Launches A New Program to Enhance and Sustain Long-Term Mental Health

2 years ago

The post-program content will be offered after the 12-week program and is aimed to help graduates sustain change to ensure…

Compassionate Use Case Study Demonstrating the Potential of Investigational Direct Lytic Agent Exebacase to Treat MRSA Bacteremia in Pediatric Populations Published in Clinical Infectious Diseases

2 years ago

Data from Single Pediatric Patient Highlights that FDA-Designated Breakthrough Therapy Exebacase May be a Beneficial Adjunctive Therapy for Severe MRSA…

Dr. Jessica Hopfield Appointed to Berkeley Lights Board of Directors

2 years ago

Addition of Experienced Independent Director with Accomplished Business Record Underscores Berkeley Lights Board of Directors’ Commitment to Delivering Value for…

Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental Health

2 years ago

Technology will save practitioners and patients time during motor threshold determinationMALVERN, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc.…

Bioventus Receives US FDA Clearance for BoneScalpel® Access™

2 years ago

DURHAM, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in…

BREXAFEMME® (ibrexafungerp tablets) Added to Major National Formulary, Providing Access for Millions More Commercially Insured Patients

2 years ago

A novel first-in-class, one-day oral antifungal treatment, BREXAFEMME is now covered for more than 45% of commercially insured patients in…